Celtic Biotech Iowa Licenses a Propitious Therapy for Acute and Chronic Nephropathy
WEST DES MOINES, IA: Spotlight Innovation – a provider of solutions for healthcare-focused companies, has announced that its subsidiary Celtic Biotech Iowa –a developer of novel clinical trial-phase therapeutic products for the treatment of cancers and pain in humans has entered into an exclusive, world-wide (excluding China) license agreement.
The agreement focuses on developing and marketing a patent-pending invention related to the treatment of acute and chronic nephropathy, Use of Cardiotoxin for the Treatment of Chronic Kidney Disease (CKD). Animal studies have shown that cardiotoxin has the ability to inhibit the immune processes that damage the kidneys. This will help to reduce the level of proteinurea, serum creatinine and urea in chronic neuropathy, and recover renal function and reduce renal injury.
"This CKD therapy has shown the potential to improve kidney function in a variety of animal models, and we expect to see comparable effectivity as we move this therapy through the clinical trial process. For those people who have experienced kidney failure due to chronic kidney disease, there are currently only two options for treatment -- life-long dialysis or kidney transplant. We would hope that this therapy could be utilized to delay or stop the progression to dialysis or surgery,” says Dr. Paul Reid, President, Celtic Biotech Iowa.
By Nancy S. Wolk, CIO, Alcoa - Global Business Services
By John Kamin, EVP and CIO, Old National Bancorp
By Gregg T. Martin, VP & CIO, Arnot Health
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
By Bryson Koehler, EVP & CIO, The Weather Company, an IBM...
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Adrian Mebane, VP-Global Ethics & Compliance, The Hershey...
By Lowell Gilvin, Chief Process Officer, Jabil
By Dennis Hodges, CIO, Inteva Products
By Gerri Martin-Flickinger, CIO, Adobe Systems
By Walter Carvalho, VP& Corporate CIO, Carnival Corporation
By Mary Alice Annecharico, SVP & CIO, Henry Ford Health System
By Bernd Schlotter, President of Services, Unify
By Bob Fecteau, CIO, SAIC
By Kushagra Vaid, GM, Server Engineering, Microsoft
By Steve Beason, Enterprise CTO, Scientific Games
By Steve Bein, VP-GIS, Michael Baker International
By Jason Alan Snyder, CTO, Momentum Worldwide
By Jim Whitehurst, CEO, Red Hat
By Alberto Ruocco, CIO, American Electric Power